Accelagen Staff Announcement: Melanie Scheepers

March 20, 2022

Accelagen is thrilled to welcome Melanie Scheepers to the Accelagen team as the company’s first dedicated Pharmacovigilance Associate.

Our business continues to grow rapidly in Australia, and we are building our team to support that growth.

Melanie is a highly experienced PV and Safety leader with over 2o years’ international and local experience. After completing a Bachelor of Science from Queensland University of Technology, she began her career working for Australian Nutraceuticals in the QC laboratory as a chemist. She later moved to the UK and began learning the ropes of Pharmacovigilance at Novartis, where she worked for five years. Melanie eventually moved back to Australia in a similar role at the same company, and later established the PV department for the ANZ region at Lundbeck. Interested in exploring a CRO environment, she has spent the last decade working in various Safety lead roles to understand the clinical space.

Joining Accelagen in 2022, Melanie is overseeing the establishment of a robust PV system across various projects for both Clinical Research and Post Marketing products covering the full lifecycle of medicinal products. She manages all processes and procedures related to PV and Safety, and works closely with our CEO in bringing together all departments and third parties to plan and run annual training.

As Australia’s reputation as a destination for CROs grows, Melanie is playing a vital role in the foundation team that is helping to cement Accelagen’s upward trajectory in this market. Her expectations of excellence and knowledge of safety are an invaluable asset to the team.

Recently relocating to Brisbane, Melanie is a passionate artist, traveller, snorkeller and reader, and is also part way through a Masters in Pharmaceutical Medicine.

Welcome Melanie!